Tranexamic Acid in Breast Esthetic Surgery.

Summary

The investigators prepared a novel tranexamic acid (TXA) study designed to estimate the quantity of blood loss in patients undergoing breast esthetic surgery. This study aims to quantify blood loss during abdominoplasty with and without TXA. The central hypothesis is that TXA administration reduces blood loss and fibrinolysis in breast esthetic surgery patients.

Timeline

Start

2023-09-15

Primary completion

2025-09-30

Completion

2025-09-30

Drugs

Indications